DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Russell JA, Vincent JL, Kjølbye AL. et al.
Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients.
Crit Care 2017;
21 (01) 213
We do not assume any responsibility for the contents of the web pages of other providers.